Indonesia vs Senegal: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Indonesia
78.0%
in 2025
Senegal
78.0%
in 2025
Indonesia rank
117th
Senegal rank
117th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Indonesia
- Senegal
How they compare
Indonesia currently reports 78.0% against 78.0% in Senegal, a difference of 0.0%.
The two have swapped places 8 times across 26 shared years of data; in 2000 it was Senegal ahead.
Indonesia ranks 117th and Senegal ranks 117th of 194 countries.
Across the 3 decades both report, Indonesia averaged higher in 2 and Senegal in 1.
Head to head by decade
| Decade | Indonesia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.9% | 0.0% | 32.9% | Indonesia |
| 2010s | 61.9% | 30.8% | 31.1% | Indonesia |
| 2020s | 68.8% | 71.2% | 2.3% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Indonesia or Senegal?
- Indonesia, at 78.0% against 78.0% in Senegal as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Indonesia and Senegal?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Senegal?
- 26 years are reported by both, from 2000 to 2025.
- How do Indonesia and Senegal rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Indonesia ranks 117th and Senegal ranks 117th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.